Latest Shareholder Value News

archTIS has reported a standout March quarter with record annual recurring revenue, improved gross margins, and strategic growth through the Direktiv acquisition and new international contracts.

Mad Paws Holding Limited reported a robust 22% year-on-year growth in Gross Merchandise Value over March-April 2025, driven by marketplace momentum despite a 6% decline in group operating revenue. Strategic marketing campaigns and operational enhancements underpin the company’s growth trajectory.

Dalaroo Metals has taken a strategic step into Greenland’s critical metals scene with an option to acquire the Blue Lagoon Zr-Nb-REE Project, while advancing promising base and copper metal prospects at its Lyons River Project in Western Australia.

Santos Limited's 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet highlights progress in carbon capture and storage and emissions reduction. The company maintains a strong balance sheet while advancing its climate transition strategy.

Santos Limited's 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet highlights significant progress in carbon capture and storage and emissions reduction efforts. The company remains committed to its net-zero targets and sustainable growth strategy.

Santos Limited’s 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet the company delivered a solid $1.224 billion net profit while making significant strides in carbon capture and storage and emissions reduction.

Santos Limited’s 2024 Annual Report reveals a 5% drop in production and a 9% fall in sales revenue, yet the company maintains strong profitability and advances its carbon capture and storage projects alongside ambitious climate goals.

Loyal Lithium bolsters its North American lithium portfolio with significant exploration advances at Trieste and strategic board appointments, positioning itself strongly for the electric future.

FireFly Metals reports robust March quarter results, highlighting significant drilling success at its Green Bay Copper-Gold Project and a well-funded position to advance large-scale mining studies.

Island Pharmaceuticals has completed dosing in the Phase 2b cohort of its dengue fever trial, with pharmacokinetic targets met and top-line results expected next month. The company also strengthened its balance sheet by raising $1.94 million through option exercises.

Santos Limited’s 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet the company progresses its climate ambitions with the successful Moomba CCS project and robust decarbonisation efforts.

CurveBeam AI Limited reported a $4.367 million net operating cash outflow for Q3 2025 but anticipates a significant improvement in cash flow driven by device installations and customer receipts, with no immediate plans for capital raising.